Guest guest Posted April 22, 2002 Report Share Posted April 22, 2002 Hello Group, I was reading on Charmayne's Site about a clinical trial on " Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor to Treat Progressive Supranuclear Palsy " . Just wondering if any of you more scientific types happen to know if the potential benefits of this therapy (if it works) are expected to be limited to PSP or is there the hope that this therapy could also help MSA and/or Parkinsons patients? Jerry Cash Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.